达芬奇机器人辅助腹腔镜行前列腺癌根治术的探讨

Clinical feasibility of Da Vinci robot-assisted laparoscopic radical prostatectomy in prostatic cancer patients

目的探讨在前列腺癌根治术患者的外科手术中引入微创理念并辅以达芬奇手术机器人的临床治疗可行性。方法筛选我院2018年1月-2019年3月收治的因患前列腺癌入院寻求治疗介入的患者80例,取其中40例作对照组,予以常规腹腔镜前列腺癌根治术(LRP);另40例患者作实验组,予以达芬奇机器人辅助腹腔镜前列腺癌根治术(RALRP)。观察两组手术时间及出血量、手术输血率、疼痛情况、住院时间及治疗费用差异。结果实验组术中出血量、术时、围术期输血率、住院时长及术后疼痛情况均较对照组更优,而对照组治疗费用较实验组更佳,均P<0.05。结论推荐对经济性无要求的患者予以RALRP治疗,围术期治疗指标较LRP可获进一步优化,患者短期预后佳,值得推广。

Objective To explore the clinical feasibility of minimally invasive surgery via Da Vinci robot in prostatic cancer patients.Methods 80 prostatic cancer patients treated from January 2018 to March 2019 in our hospital were selected and assigned to control group(n=40)and test group(n=40).The control group was treated with laparoscopic radical prostatectomy(LRP);the test group was treated with Da Vinci robot-assisted laparoscopic radical prostatectomy(RALRP).The operation time,intraoperative blood loss,transfusion rate,pain degree,hospitalization time and treatment costs were compared.Results The intraoperative blood loss,operation time,transfusion rate,hospitalization time and pain degree in the test group were better than those of control group;the treatment costs in the control group were better than those of test group(P<0.05).Conclusion For patients without economic burdens,RALRP can optimize the perioperative indicators and improve the short-term prognosis.It is worthy of promotion.